News Focus
News Focus
Followers 5
Posts 973
Boards Moderated 0
Alias Born 03/03/2011

Re: investorgold2002 post# 7128

Saturday, 10/29/2011 10:12:09 AM

Saturday, October 29, 2011 10:12:09 AM

Post# of 20689
FOB speculation

the "FOB platform" patents that MNTA has (Eg: Host cell line selection) could block competition(biogeneric type) in a NUMBER OF BIOLOGICS and not just 1 biologic.

Is this an extreme assumption ? If the above is true, there should be a beeline of Big Pharma wanting to partner with Momenta. Of course this is after FDA announces the official pathway for biogenerics